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Abstract:  The sequence-independent single primer amplification (SISPA) method was 
performed to identify a virus in 17 clinical respiratory samples producing uncharacterized 
cytopathic effects in LLC-MK2 cells. Sequence analysis of 600-1600 bp amplicons 
allowed the identification of six viruses (one influenza C, two parechovirus-3 and three 
cardioviruses). Genomic sequences of the cardioviruses showed similarities with those of 
the recently-described Saffold virus strain although significant variation was present in the 
viral surface EF and CD loops. These results demonstrate the usefulness of SISPA for 
identifying emerging viruses and also known viruses not easily identified by standard 
virological methods. 
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Introduction 
Respiratory viral infections (RVIs) are a major cause of morbidity and mortality worldwide. RVIs 
can be associated with a variety of clinical symptoms ranging from self-limited infections to more 
devastating conditions such as pneumonia 1. Despite the use of a variety of laboratory diagnostic 
methods, in  50% of cases of community-acquired pneumonia in adults and in 15-35% of cases of 
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bronchiolitis and pneumonia in children an etiologic agent still cannot be identified  2, 3.  It is likely 
that still unidentified viruses, as well as those that cannot be easily detected by current diagnostic 
methodologies, are responsible for the vast majority of unknown respiratory syndromes. 
Each year, an average of 7000 clinical samples are sent to the Regional Virology Laboratory of 
Québec City (Province of Québec, Canada) for viral identification using antigen detection tests, cell-
culture based techniques and PCR/RT-PCR assays. Interestingly, for a few samples, viral identification 
could not be achieved despite the presence of cytopathic effects (CPE) that could be observed in one or 
more cell lines. The aim of this study was to assess the ability of the sequence-independent single 
primer amplication (SISPA) method to identify some viruses producing uncharacterized CPE. This 
method, previously described in 2001 by Allander and colleagues 4, demonstrated efficacy in 
identifying known and new DNA and RNA viruses from clinical samples 4-6. 
Results and Discussion 
Among the 17 clinical respiratory samples tested, the SISPA method allowed the identification of 
six viruses (Table 1). The latter viruses originated from four nasophayngeal aspirates (NPA) and two 
bronchoalveolar lavages (BAL). The identified RNA viruses consisted of influenza C virus which 
belongs to the Orthomyxoviridae family (one case), human parechovirus type 3 (HPeV-3) which 
belongs to the Picornaviridae family (parechovirus genus) (two cases) and cardiovirus Saffold-like 
virus which belongs to the Picornaviridae family (cardiovirus genus) (three cases). All 17 samples 
gave positive CPE when cultured on LLC-MK2 cells. The Canadian cardiovirus Can112051-2006 also 
presented CPE on Hep2 cells. The mean time to first CPE detection in LLC-MK2 cells was 19, 6 and 4 
days for influenza C, HPeV-3 and cardioviruses, respectively (Table 1). The absence of commercially-
available monoclonal antibodies and/or the novelty of these viruses precluded their rapid identification 
in the clinical virology laboratory. For instance, influenza C viruses display a poor growth in cell 
culture and are not typically identified by DFA or ELISA assays 7.  HPeV-1 and -2 (formerly 
echoviruses 22 and 23) have been known for years 8. Recently, a variety of new HPeV types have 
been described 8. RT-PCR assays based on the amplification of 5’ untranslating region (UTR) of 
enteroviruses will not detect parechoviruses because of significant genome sequence differences 
between these two viral genera 9.  Previous studies demonstrated that most HPeV-3 infections were 
associated with cases of neonatal sepsis 10, 11. By contrast, the two HPeV-3 infections from this 
study were both associated with pneumonia, one in a 37-year old immunocompromised patient and the 
other in a 61-year old immunocompetent patient. Of note, the BAL of both patients also grew 
cytomegalovirus. Thus, the exact contribution of HPeV-3 infections in these two clinical cases remains 
unclear.  
The Saffold virus, a recently identified cardiovirus, was initially isolated from the stool of a 8-
month old girl who presented with fever of unknown origin 6. The complete genomic sequence of 
this strain (OSV) was subsequently published in GenBank (accession number EF165067). Our three 
Saffold cardiovirus strains were recovered from NPA samples of children including a 23 month-old 
patient who was hospitalized for respiratory symptoms (fever, cough, rhinorrhea, otitis) (case 1), a 19 
month-old patient who was hospitalized for a suspicion of bacteriemia and cold (case 2) and a 48 
month-old patient who was hospitalized for pneumonia and otitis (case 3). The three Canadian strains Viruses 2009, 1                                       
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were closely related based on partial sequences of the VP1 and VP2 genes 12. The complete 
polyprotein sequence was determined for one of our Canadian Saffold viruses (Can112051-06) 
(GenBank accession number AM922293). Subsequently, another Saffold virus strain (UC1) was 
detected in respiratory secretions of a child with influenza-like illness 13 and its complete genomic 
sequence has also been published (GenBank accession number YP_001949875). The Saffold virus is 
the first human virus part of the cardiovirus genus which contains two animal species i.e 
encephalomyocarditis virus species (mengovirus and EMCV) and Theilovirus species (TMEV, 
Theiler-like virus and Vilyuisk virus) 14. Phylogenetic analyses suggest that Saffold viruses qualify 
as divergent members of the Theilovirus species 15. Comparaison of whole polyprotein sequences 
(2293 a.a) shows that our Canadian prototype isolate is more related to the UC1 Saffold strain than to 
the prototype OSV Saffold strain  from California (USA) sharing respectively 99.1% and 91.2% amino 
acid (a.a.) identities with these two strains.  
The viral surface of cardioviruses contains four small loops, two of them are part of the EF loop 
structure within the VP2 protein whereas the two others are part of the CD loop structure within the 
VP1 protein. The EF loop structure of Can112051-06 strain has 100% and 61.8% a.a. identity with that 
of UC1 and OSV, respectively (Figure 1A). Similarly, the CD loop structures of Can112051-06 and 
UC1 are identical and share 67.5% a.a. identity with that of OSV (Figure 1B). Since the EF and CD 
loop structures are exposed on the viral surface of cardioviruses, they may constitute important sites 
for recognition by neutralizing antibodies 16. A possibility thus exists that Can112051-06 and UC1 
strains might belong to the same serotype, which could be different than the one represented by OSV.  
However, further serological studies are needed to verify this hypothesis.  
Only 6/17 cases of this study were successfully identified using the SISPA method. Of note, most 
of the identified viruses (5/6) belong to the Picornaviridae family, suggesting that the primers used for 
the cDNA synthesis and PCR, although randomly selected, are likely to be more suitable for the 
identification of picornaviruses. It would be interesting to evaluate the same SISPA approach by using 
different primers for identification of the remaining 11 cases of this study. The ability of the SISPA 
method to identify viruses directly from clinical specimens also remains to be investigated although 
this method should not be viewed as a primary laboratory detection method such as antigen assays, cell 
culture or PCR-based approaches. Obviously, the sensitivity of virus-specific RT-PCR tests is 
expected to be significantly higher than SISPA either by using cell culture supernatants or clinical 
specimens. Therefore, judicious use of such specific tests for viral identification at the family/genus 
level could decrease the need for more generic methods such as SISPA. Nevertheless, all specific PCR 
tests could not be performed in the routine clinical setting considering the large number of described 
respiratory viruses and yet-to-discover pathogens.  
In addition to the SISPA method which can be performed in most clinical laboratories, additional 
strategies requiring specific equipments such as high throughput pyrosequencing 17 and the pan-viral 
microarray (Virochip) 18 have also proven to be interesting alternatives for the diagnosis of viruses 
that could not be identified by conventional assays.  
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Table 1. Identification of viruses by using the SISPA method. 
         Isolate/year  Specimen  Virus  Time to CPE 
    Can90775/2003  NPA  Influenza C  19 days 
Can101516/2005 BAL  HPeV-3  6  days 
Can101519/2005 BAL  HPeV-3  6  days 
Can112051/2006  NPA  Cardiovirus Saffold  4 days 
Can116603/2006  NPA  Cardiovirus Saffold  4 days 
Can116604/2006  NPA  Cardiovirus Saffold  4 days 
NPA, nasopharyngeal aspirate; BAL, bronchoalveolar lavage; HPeV, human 
parechovirus;   CPE, cytopathic effects. 
Figure 1. Amino acid sequences of the EF loop (part of the VP2 protein) (A) and the CD 
loop (part of the VP1 protein) (B) of a Canadian cardiovirus (Can112051-06, GenBank 
accession number AM922293), other cardioviruses including the original Saffold virus 
strain (OSV, accession number EF165067) and the UC1 strain (accession number 
YP_001949875), Theiler’s murine encephalomyelitis virus (TMEV, accession number 
NP_040350) and Theiler’s-like virus (accession number BAC58035). Amino acid 
differences between Can112051, UC1 and OSV strains are shaded. 
A 
         EF Loop (I)                 EF Loop(II) 
 
                  10        20        30        40        50 
                        |         |         |         |         | 
Can112051/06   PEFDTSPYNATTEPTKAVPFQMDTQWQSG--KLLGHSYESTTLQGLRPLALNHQNHW 
UC1            PEFDTSPYNATTEPTKAVPFQMDTQWQSG--KLLGHSYESTTLQGLRPLALNHQNHW 
OSV            PEFDTSSYSAVDDPIGEEPFKVDTTWQTG--SLRGHSYEDKSTQTLRPLALNHQNYW 
TMEV           PEFYTGKGTKSGTMEPSDPFTMDTTWRSPQSAPTGYRYDRQAG----FFAMNHQNQW 
Theiler-like   PEFYTGHTPVTGTTEPATPFTMDSSWQTPQQNPVGFRYDGRTG----YFALNHQNYW 
 
B 
           CD Loop (I)       CD Loop(II) 
 
                  10        20        30        40 
                        |         |         |         | 
Can112051/06   LTPLPSNRLDDSTYG-----LAEQHRWLSFPTDTKQTPPYKTKQD 
UC1            LTPLPSNRLDDSTYG-----LAEQHRWLSFPTDTKQTPPYKTKQD 
OSV            LTPLPSDRLKENEFG-----LDEQHRWLSFQSATSSTPPYRTKQD 
TMEV           LTPLPS-YCPDSSSGPVRTKAPVQWRWVRSGGANGANFPLMTKQD 
Theiler-like   LTPLPS-YAPDSTTGPTETQAPIQWRWLRGTSDGSTTFPLMTKQD 
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Experimental Section 
A panel of 17 clinical respiratory samples collected between 2003-2006 were selected for this 
study. Identification of viruses from these samples was first attempted by using cell culture-based 
techniques that consisted of inoculating a panel of cell lines including human laryngeal carcinoma 
(Hep-2), human foreskin fibroblast, Vero (African green monkey kidney), Mink lung, human lung 
adenocarcinoma (A-549), human rhabdomyosarcoma (RD), transformed human kidney (293), human 
colon adenocarcinoma (HT-29), Madin Darby canine kidney (MDCK) and  rhesus monkey kidney 
(LLC-MK2) cells. The presence of CPE or a positive hemadsorption test prompted the performance of 
immunofluorescent assays for enteroviruses (Pan-Enterovirus Blend kit; Light Diagnostics, 
Levingston, UK), influenza A and B viruses, parainfluenza viruses 1–4 and adenoviruses (Bartels; 
Trinity Biotech, Carlsbad, CA), measles and mumps viruses (Chemicon; Billerica, MA), and 
respiratory syncytial virus (RSV) (Meridian Diagnostics; Cincinnati, OH). In addition, nucleic acids 
from these 17 samples were obtained using the QIAamp Viral RNA kit (Qiagen, Mississauga, Ontario, 
Canada) and tested by multiplex real-time RT-PCR assay for the presence of common respiratory 
viruses (influenza A and B viruses, RSV and human metapneumovirus) 17.  
All 17 samples were negative for the above tests despite producing reproducible CPE in LLC-MK2 
cells. The supernatants of infected cells were filtered through a 0.22 m filter and treated with DNase I 
(Roche Diagnostics; Mannheim, Germany). DNA and RNA were separately extracted using the 
QIAamp Blood Minikit and QIAamp Viral RNA kit (Qiagen; Mississauga, Ontario, Canada), 
respectively. Nucleic acids were then used in the SISPA method which was performed as previously 
described 4. For RNA virus detection, 10 L of extracted RNA were incubated with 2 L (10 M) of 
the random SISPA-A primer (5’-GTTCCCAGTCACGATCNNNNNN-3’) for 5 min at 650C, and 
chilled on ice. Then a 8.7 L reaction mix containing 4 L of 5x First-Strand buffer (Invitrogen; 
Carlsbad, CA), 2 L of 100 mM DTT, a 2-L solution containing each dNTP at 5 mM, 0.2 L of 
RNase inhibitor (Promega; Madison, WI) and 0.5 L (100 units) of SuperScriptII reverse transcriptase 
(Invitrogen; Carlsbad, CA) was added. The reaction was incubated at 25°C for 10 min and at 42°C for 
50 min. After a denaturation step of 3 min at 94°C and chilling on ice, 2.5 units (0.5 L) of 3’-5’ exo- 
Klenow DNA polymerase (New England Biolabs) were added and the reaction was incubated at 37°C 
for 1 h. The enzyme was inactivated at 75°C for 10 min and, finally, 5 L of the resulting double-
stranded cDNA were used for PCR amplification using the SISPA-B primer (5’-GTTCCCAGTCACG 
ATC-3’) and the PFU Turbo DNA polymerase (Stratagene, La Jolla, CA) following the manufacutrer’s 
recommendations. PCR conditions included a denaturation step of 10 min at 94°C, followed by 40 
cycles of amplification (94°C for 1 min, 65°C for 1 min and 72°C for 2 min). After a 1.2% agarose gel 
electrophoresis, PCR products of 600-1,600 bp were purified using the gel-extraction kit (Sigma-
Aldrich; Oakville, ON) and cloned using the CloneJET PCR Cloning Kit (Fermentas; Burlington, ON). 
Two recombinant plasmids for each insert were sequenced before comparison with GenBank database 
using the tBLASTx program. For DNA virus detection, we used the same conditions as previously 
described 4. 
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Conclusions 
Our study highlights the limitation of conventional virological diagnostic methods as well as 
selected molecular PCR assays for identification of emerging or non-conventional viruses and 
confirms the usefulness of a new method based on random PCR amplification i.e. SISPA. Using this 
relatively simple method, we were able to identify rare (influenza C) or emerging (HPeV-3, 
cardiovirus Saffold) viruses  in 6/17 (35%) respiratory samples associated with uncharacterized CPE in 
cell culture.  
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